- Benchmark ASINB0FVZH4C65
- MarketplaceUS
- Category ID16310091
- Analyzed Products
- Keywordhydrocolloid roll bandage, hydrocolloid wound dressing roll, medical hydrocolloid tape
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-26
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不建议进入，已经是明显的过热价格战区。 新品牌数量高达71个，远超30~100+的过饱和警戒；新品牌新品盈利率只有21.62%，但非盈利样本有114个，近8成新品都没赚到钱，说明大多数入场者只能被迫卷低价、卷规格、卷包装，市场不是“能不能做”，而是“谁先被利润挤死”。
证据很直接：新品利润率分布里，能赚钱的新产品只有32个，而123个新品不赚钱；入场时间越往后，赚钱样本并没有明显变好，反而最近持续有大量失败款出现，说明竞争在加速恶化。典型亏损样本里，YHOVID 的 B0F93BXWTS 只有 8.54% 利润，SafeFight 的 B0FR8F19KD 是 -29.14%，Zoomcritter 的 B0FNR2336S 只有 7.93%；而看起来能跑出来的款，几乎都靠“可裁剪长卷 + 低价 + 轻差异化”，比如 KissYee 的 B0GWCX7Q1L 月销 7000、利润率 31.09%，但它的成功并不稳定：同品牌还有 B0FQ9TQ733、B0FV1684HY 失败。对小商家来说，这已经不是正常竞争，而是需要接近掠夺式营销才能勉强进场；对大品牌来说，虽然资金上能扛，但也必须有明确的产品升级、认证、设计差异，否则一样会被压进低毛利。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing这个市场不适合现在进入。 不是单纯“有机会”，而是已经进入明显的价格战和挤压期：新品牌一旦进来，亏损/低利润样本占比很高，成功并不稳定；小品牌更不该硬冲，大品牌即使能砸钱，也只能在少数具备认证、差异化和品牌势能的款式里勉强打。
Early sourcing + logistics + marketing budget (USD)$800.70 - $16,851.60Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?5.09%New listing success rate (old brands):0.00%New listing success rate (new brands):21.62%Which new brands have these successful new listings?...Alternatives- 普通水胶体敷料贴/预裁水胶体创可贴：直接买成品贴片，省去裁剪步骤，单次使用更省心，适合想快速处理小伤口、脚后跟磨破和痘痘护理的用户。
- 防水PU透明敷贴（非水胶体）：通常比水胶体卷更容易买到、价格更低，适合日常小擦伤、固定纱布和短时防水保护，虽然吸液能力较弱，但对不渗液伤口更实用。
- 医用硅凝胶疤痕贴/固定贴：对轻微术后护理、皮肤敏感用户更友好，舒适度高、撕除更温和，适合不想要强粘性水胶体的人群。
- 无菌纱布+低敏医用胶带组合：几乎所有药房都能买到，成本通常更低，覆盖伤口更灵活，适合渗出量不大、需要频繁更换敷料的场景。
- 液体创可贴：对手指小裂口、倒刺、浅表划伤更方便，不需要裁剪和贴合边角，适合追求快速涂抹、短时防护的用户。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，已经进入价格战区，且新品牌扎堆，风险很高。 关键不是“有没有机会”，而是大多数新入场都在亏钱：新品牌新上架盈利率只有21.62%，非盈利率高达77.03%；近一年新品牌新上架数量明显抬升，2025年爆发式增加，2026年继续高位运行，说明竞争在加剧而不是收缩。
Most investment in new productsNew products with Highest revenueKissYee
Recent Monthly Revenue (USD):$138,040.00(7000pcs/month)B0GWCX7Q1L (4.5/5 (838 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$94,990.00(7000pcs/month)B0FQJ922HN (4.5/5 (840 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$46,990.00(3700pcs/month)B0FQJG5TVP (4.5/5 (838 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsYHOVID
Recent Monthly Revenue (USD):-(-)B0H3SYBK6BBrand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0H6ZNPCRYBrand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$8,874.00(900pcs/month)B0F93BXWTS (4.5/5 (1575 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Least investment in new productsSafeFight
Recent Monthly Revenue (USD):-(-)B0FZFY31CZBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$954.00(200pcs/month)B0FR8F19KD (4.4/5 (76 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatNet profit margin below 10.00%
Recent Monthly Revenue (USD):$1,318.00(200pcs/month)B0FR9KVBBS (4.3/5 (72 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Least profitable new productsZoomcritter
Recent Monthly Revenue (USD):-(-)B0FNR2336S (4.1/5 (11 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0FNR19P5S (4.1/5 (11 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0FNQZYXG2Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 蓝白医疗认证包装，专业感最强，图片更容易获得点击
- |
- 与常见痘痘贴不同，强调Dermatest认证和高皮肤友好度
- |
- 卷装可按需裁剪，适合痘痘、水泡、烫伤等多场景
B0GF4GZ9FG (5/5 (7 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 半透明隐形外观，贴上后更不显眼，吸引日常使用者
- |
- 2英寸×16英尺超长卷装，尺寸感最突出，差异化强
- |
- 主打大面积可裁剪，适合背部痘痘、成片擦伤和纹身护理
B0G6K9NK3B (4.4/5 (41 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing不建议进入，这个市场已经明显过热，属于高风险价格战市场。 新品里可识别利润率只有20.38%能赚钱，但按已知利润分布看，低于10%的产品占比接近一半，0~10%与亏损段合计非常高，说明大多数卖家是在薄利甚至亏损硬撑，竞争已经把利润压得很低。
Profitability difficultyModerate Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0GWCX7Q1LKissYee2026-04-29Yes$19.727000pcs$138040.031.09%$42916.64B0FQJ922HNKissYee2025-11-05Yes$13.577000pcs$94990.022.67%$21534.24
B0GGZ6GTZYDimora2026-04-30Yes$21.022000pcs$42040.030.47%$12809.59B0FQJG5TVPKissYee2026-02-03Yes$12.73700pcs$46990.020.11%$9449.69
B0FPCSW4HPKOVOQ2025-09-22Yes$19.15400pcs$7660.022.06%$1689.8B0G6K9NK3BDooWee2026-01-01Yes$13.98600pcs$8388.019.57%$1641.54
B0FBR1Y8FXPhyyixs2025-07-22Yes$12.12800pcs$9696.014.97%$1451.5
B0GWCT327HKissYee2026-04-29Yes$14.02400pcs$5608.023.67%$1327.42
B0FCDZ5GD6Dkmord2025-06-09Yes$20.58200pcs$4116.030.27%$1245.92B0FVZH4C65Pellipatch2025-11-15Yes$19.99200pcs$3998.028.61%$1143.83
B0FWRM5PXVTKTK2025-11-20Yes$15.86300pcs$4758.023.85%$1134.79
B0G6S3S7BFSUBEFA2025-12-13Yes$11.1600pcs$6660.016.92%$1126.88
B0GSP9JJX5Daltura2026-03-20Yes$16.98250pcs$4245.024.44%$1037.48
B0FLPBFYT4Bioemmalab2025-11-10Yes$12.13450pcs$5458.516.37%$893.56
B0FCYDR589Dkmord2025-06-12Yes$12.99300pcs$3897.021.44%$835.52
B0FPCRYWH6KOVOQ2025-09-01Yes$15.11250pcs$3777.521.62%$816.7
B0GDYDFZHKLIFARA2026-01-04Yes$11.64500pcs$5820.013.71%$797.93
B0F5WXFVX8LukToMao2025-04-22Yes$14.52200pcs$2904.024.59%$714.1
B0H1LMCDTLyarster2026-05-13Yes$12.44300pcs$3732.017.66%$659.08
B0GYRYLP3Hyarster2026-04-28Yes$14.7200pcs$2940.021.48%$631.52Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GWCX7Q1LKissYee2026-04-29Yes$19.727000pcs$138040.031.09%$42916.64B0FQJ922HNKissYee2025-11-05Yes$13.577000pcs$94990.022.67%$21534.24B0GGZ6GTZYDimora2026-04-30Yes$21.022000pcs$42040.030.47%$12809.59B0FQJG5TVPKissYee2026-02-03Yes$12.73700pcs$46990.020.11%$9449.69B0FPCSW4HPKOVOQ2025-09-22Yes$19.15400pcs$7660.022.06%$1689.8B0G6K9NK3BDooWee2026-01-01Yes$13.98600pcs$8388.019.57%$1641.54B0GWCT327HKissYee2026-04-29Yes$14.02400pcs$5608.023.67%$1327.42B0FVZH4C65Pellipatch2025-11-15Yes$19.99200pcs$3998.028.61%$1143.83B0FWRM5PXVTKTK2025-11-20Yes$15.86300pcs$4758.023.85%$1134.79B0G6S3S7BFSUBEFA2025-12-13Yes$11.1600pcs$6660.016.92%$1126.88B0GSP9JJX5Daltura2026-03-20Yes$16.98250pcs$4245.024.44%$1037.48B0FLPBFYT4Bioemmalab2025-11-10Yes$12.13450pcs$5458.516.37%$893.56B0FPCRYWH6KOVOQ2025-09-01Yes$15.11250pcs$3777.521.62%$816.7B0GDYDFZHKLIFARA2026-01-04Yes$11.64500pcs$5820.013.71%$797.93B0H1LMCDTLyarster2026-05-13Yes$12.44300pcs$3732.017.66%$659.08B0GYRYLP3Hyarster2026-04-28Yes$14.7200pcs$2940.021.48%$631.52
B0GCFT2ZNBLIFARA2025-12-24Yes$12.37300pcs$3711.016.47%$611.21
B0GY1B1S5BXANBYYE2026-04-21Yes$23.18100pcs$2318.025.62%$593.88
B0FXVJ4R7MAkgen2025-10-26Yes$12.04250pcs$3010.018.08%$544.21
B0FQH6QHFZHONKID2025-08-24Yes$13.87150pcs$2080.523.24%$483.51#New Product Success Rates
Listing这个市场不适合进入，结论很直接：新品牌成功率只有20.38%，但老品牌新上架产品100%都不赚钱，说明市场已经进入高压竞争区，且新品牌要想站稳几乎只能靠少数强势打法。 更关键的是，真正的“可复制小商家成功”几乎看不到，反而有明显的旧品牌压制和大量失败新款，属于高风险、低容错市场，不建议现在入场。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
KissYeeOtherNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Other#Success Rate by Entry Time
Listing这个市场已经明显过热，不建议进入。 近一年新品牌涌入很多，但成功率只有 21.92%，而最近新增的失败数量远高于成功，说明竞争正在加速变难；更关键的是，最近的胜出几乎都靠“卷装可裁剪 + 低价 + 轻度差异化”，不是靠真正稀缺创新，后进者很容易被卷进价格战。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 7 5 14 10 10 0 0 67 2026 1 0 1 5 5 2 0 30 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 2 0 0 0 0 0 2025/8 3 3 1 1 1 0 0 16 2025/9 2 2 5 3 6 0 0 21 2025/10 1 0 0 1 0 0 0 11 2025/11 0 0 4 1 3 0 0 12 2025/12 1 0 2 4 0 0 0 7 2026/1 1 0 0 3 0 0 0 6 2026/2 0 0 0 0 1 0 0 0 2026/3 0 0 0 0 1 0 0 8 2026/4 0 0 1 0 3 2 0 5 2026/5 0 0 0 2 0 0 0 7 2026/6 0 0 0 0 0 0 0 2 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesLukToMaoB0F5WXFVX8 (4.6/5 (559 Reviews))Hydrocolloid Roll, Waterproof Bandage, Wound Dressing, Pimple Patch Roll
This listing is deemed profitablePrice (USD)$14.52Released TypeOld Release (2025-04-22)Brand is an old entry in this marketSize and Weight5.5 x 5.4 x 5.3 cm, 68.00gProfitable Factors
Based on old ASINDistinct functions and featuresLow pricing strategyDesign & Appearance
卷装可裁剪设计，适合按需剪成小块或大块Key Buying Motive
卷式可裁剪，兼顾伤口覆盖、足部水泡保护和痘痘点涂Target Customers
需要一卷多用、可按部位自由裁剪的家庭急救与运动人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$2,904.00200 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight22.76% / 24.59%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight20.48% / 22.31%Peak / Non PeakSales & BSR Performance
GALAXY BEAUTYB0FHMKCCC3 (4.2/5 (49 Reviews))Hydrocolloid Roll – Cut-to-Size Waterproof Dressing Tape – Flexible & Skin-Friendly Bandage Patch for Blisters, Acne, Minor Wounds – Self-Adhesive & Latex-Free (2inch x 16ft)
This listing is deemed profitablePrice (USD)$15.48Released TypeOld Release (2025-07-15)Brand is an old entry in this marketSize and Weight8.1 x 8.0 x 6.2 cm, 181.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
2英寸×16英尺长卷装，覆盖长度在同类中更偏大规格Key Buying Motive
可按需裁剪，兼顾水胶体敷料和痘痘贴/小创口护理，使用场景更灵活Target Customers
需要长卷可裁剪敷料、同时覆盖痘痘护理与轻微伤口护理的家庭用户和随身急救用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$774.0050 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight20.08% / 22.20%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight14.39% / 16.51%Peak / Non PeakSales & BSR Performance
Loading samples... 8%